Dermatology NewsChildren with psoriasis face multitude of comorbiditiesJuly 15, 2017PsoriasisPediatricsPsoriatic Arthritis
Dermatology NewsIxekizumab helps PsA patients who failed a TNFiJuly 14, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsFirst IL-23 blocker, guselkumab, earns FDA approval for psoriasisJuly 13, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsComorbidities in psoriatic arthritis flag worse prognosisJuly 8, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsFDA approves abatacept for adults with psoriatic arthritisJuly 7, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsEarly phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsApremilast eases PsA symptoms in patients who are naive to biologicsJune 24, 2017Psoriatic Arthritis
Dermatology NewsPanel revises spondyloarthritis treat-to-target recommendationsJune 23, 2017Psoriatic Arthritis
Dermatology NewsUstekinumab trumps TNF-blockade for enthesitis in patients with psoriatic arthritisJune 17, 2017Psoriatic Arthritis
Dermatology NewsVIDEO: Guselkumab bests placebo in psoriatic arthritisJune 17, 2017Psoriatic Arthritis
Dermatology NewsPain often persists despite biologic treatment in PsAJune 16, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsExperts endorse routine screening for pediatric psoriasis comorbiditiesMay 30, 2017PsoriasisPediatricsPsoriatic Arthritis
Dermatology NewsInfliximab biosimilar noninferior to originator in IBD – NOR-SWITCHMay 23, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsAdalimumab outperforms methotrexate in treating severe pediatric plaque psoriasisMay 17, 2017PsoriasisPediatricsPsoriatic Arthritis
Dermatology NewsSome data support botulinum toxin for psoriasis and rosaceaMay 1, 2017PsoriasisPsoriatic ArthritisRosacea
_web.jpg)
